Hui Miao
Directeur/Bestuurslid bij Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Profiel
Hui Miao is currently the Director at Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Prior to this, Mr. Miao served as the President, Chief Executive Officer & Director at GuangYuYuan Chinese Herbal Medicine Co., Ltd.
from 2022 to 2024.
Mr. Miao completed their undergraduate degree at Renmin University of China.
Actieve functies van Hui Miao
| Bedrijven | Functie | Begin |
|---|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
 Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Hui Miao
| Bedrijven | Functie | Einde |
|---|---|---|
| GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Algemeen Directeur | 09-04-2024 |
Opleiding van Hui Miao
| Renmin University of China | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Health Technology |
